Company Profile

3D Biomatrix Inc (AKA: 3D Biomatrix LLC)
Profile last edited on: 12/13/2023      CAGE: 5XTX5      UEI: M18JJWUX7YG6

Business Identifier: Three-dimensional cell culture plates and scaffolds for cellular assays in drug discovery
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1600 Huron Parkway Building 520 2nd Floor
Ann Arbor, MI 48109
   (734) 272-4688
Location: Single
Congr. District: 06
County: Washtenaw

Public Profile

A University of Michigan spinout launched to serve the cancer research, stem cell research, & drug discovery and testing market with tools to grow cells and tissues for drug testing in a three-dimensional (3D) environment that mimics the human body, rather than the typical 2D environment, such as petri dishes, the firm appears to have closed operations in late 2017. 3D Biomatrix had provided three-dimensional (3D) cell culture solutions for drug discovery/testing, cancer research, and other life sciences research applications. Perfecta3D® products allow researchers to easily mimic tissue metabolic and proliferative gradients, capture complex cell-matrix and cell-cell interactions, conduct co-cultures, and monitor cell growth easily and regularly. The firm's 3D cell culture solutions boost life sciences research and drug discovery/testing applications by providing life-like results. Cells grown on 3D Biomatrix products have been shown to retain a much higher complexity of body response than traditional 2D cell cultures. 3D Biomatrix technologies have been featured on the cover of Analyst, and in Genetic Engineering and Biotechnology News, The Scientist, Bioscience Technology, Biocompare, Nature Nanotechnology, The Economist, Cosmetics Design – Europe, Pharma Discovery and Development, Nanowerk, ScienceDaily and BiotechDaily publications.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 1 NIH $233,762
Project Title: High Throughput 3d Cell Assay for Metastatic Prostate Cancer

Key People / Management

  Laura Schrader -- Former CEO (2011-2017)

  Nicholas Kotov -- CTO and Co-Founder

  Mahendra Ramsinghani -- Co-Founder

  Shuichi Takayama